Compass Pathways Plc (CMPS) is experiencing a decline in its stock price today following the announcement of a significant securities offering. The company has priced a secondary offering of approximately 24.01 million American Depositary Shares (ADSs) at $5.796 each, aiming to raise up to $353 million. This move is intended to bolster funds for ongoing Phase 3 trials for treatment-resistant depression and